Bruker Daltonics Receives Frost & Sullivan's 2002 Product Line Strategy Award.Business Editors and Health/Medical Writers BioWire 2K BILLERICA, Mass.--(BW HealthWire)--April 22, 2002 Bruker Daltonics Inc. (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on : BDAL BDAL Battle Doll Angelic Layer (game) ) today announced that it has been selected for Frost & Sullivan's 2002 Product Line Strategy Award in the US biotechnology instrumentation market. In 2001, Bruker Daltonics added eight new life-science systems to its product line. These new instruments cover a broad range of applications, including the first MALDI-TOF/TOF instrument to enter the proteomics market, as well as an innovative ESI-Q-q-TOF mass spectrometer with proprietary designs for significantly improved resolution and accuracy. This year at PITTCON PITTCON Pittsburgh Conference 2002, Bruker Daltonics announced six major product introductions involving mass spectrometry-based life science systems, in addition to significant new software capabilities for three of its bioinformatics products. Frost & Sullivan Industry Director of Research Manoj Kenkare said: "We annually present our award to the company that demonstrates the most insight into customer needs and product demands in its industry. Bruker Daltonics earned this award because of the company's optimization of its product line through designing and delivering products with the price, performance, and feature points required by the market." Frost & Sullivan Analyst Eugenia Shen Shen, in the Bible, place, perhaps close to Bethel, near which Samuel set up the stone Ebenezer. added: "We select the yearly winner by tracking end-user requirements and market dynamics within the industry. This process involves interviews with suppliers, end-users, and industry experts. The Frost & Sullivan analysts then compare company product lines with customer base demands." Dr. Frank Laukien, President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of Bruker Daltonics, commented: "We are very gratified grat·i·fy tr.v. grat·i·fied, grat·i·fy·ing, grat·i·fies 1. To please or satisfy: His achievement gratified his father. See Synonyms at please. 2. by this award, and pleased to have been recognized for our considerable emphasis on technology R&D and life-science product development." About Bruker Daltonics Bruker Daltonics is a leading developer and provider of innovative life science tools based on mass spectrometry. Bruker Daltonics is also a worldwide leader in supplying systems for substance detection and pathogen detection in security, defense and anti-terrorism. For more information about Bruker Daltonics, please visit www.bdal.com. Safe-Harbor Statement Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements of Bruker Daltonics as that term is defined in the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995. Any forward-looking statements contained herein are based on current expectations, but are subject to a number of risks and uncertainties. The factors that could cause actual future results to differ materially from current expectations include, but are not limited to, risks and uncertainties relating to technological approaches, product development, manufacturing, market acceptance, cost and pricing of Bruker Daltonics' products, dependence on collaborative partners, suppliers, FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. and other regulatory approvals to the extent applicable, competition, the intellectual property of others, patent protection and litigation An action brought in court to enforce a particular right. The act or process of bringing a lawsuit in and of itself; a judicial contest; any dispute. When a person begins a civil lawsuit, the person enters into a process called litigation. and other risk factors discussed from time to time in Bruker Daltonics' reports or filings with the Securities and Exchange Commission. Bruker Daltonics expressly disclaims any obligation to update the information contained herein. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion